Pharma & Biotech

Exelixis has ignited investor enthusiasm by reporting quarterly results that significantly exceeded market forecasts, coupled with the announcement of a...

Xoma Royalty Corporation delivered a powerful financial performance in the third quarter of 2025, significantly exceeding analyst forecasts with a...

Intellia Therapeutics is confronting one of its most severe market downturns following a cascade of negative developments that have severely...

Pharmaceutical leader Eli Lilly is making another substantial financial commitment, continuing its aggressive expansion through a major new partnership. This...

Baxter International Inc. finds its equity trading near annual lows as the medical technology company contends with a confluence of...

Natera's latest quarterly earnings report has sent its stock on a volatile ride, with investors responding enthusiastically to dramatically raised...

Assembly Biosciences shares continue to demonstrate impressive performance in the market, building on recent gains with strong technical indicators and...

Kura Oncology has achieved a significant regulatory milestone with the U.S. Food and Drug Administration granting full approval for its...

Altimmune finds itself at a critical juncture this quarter, with its shares potentially on the verge of a significant move....

The biotechnology sector has identified its latest standout performer: Axsome Therapeutics. This pharmaceutical firm is rapidly establishing itself as a...